Bioom has nearly 20 years of venture capital experience and securities analyst experience. He represents or has represented Nexus on the Boards of Presidio Pharmaceuticals, SpectraAnalysis, EyeGate Pharmaceuticals, MyoScience and Magellan Biosciences. Over the last several years, Tom has led investments in numerous successful private companies, including Panacos Pharmaceuticals and Atricure. Prior to joining Nexus, Tom ....
Access "Thomas E. Hancock" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any)
in one connected platform (AcquityData).
We use essential cookies to run this site (like keeping you signed in), and — only with your consent — analytics cookies to understand how the site is used. See our
Privacy Policy for details on what we collect and why.